-
-
-
-
-
-
-
Lipocine (LPCN) Misses Q2 EPS by 41c
-
-
-
-
-
-
-
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024
-
-
-
-
-
-
-
Lipocine Announces Financial Results for the Year Ended December 31, 2022
-
-
-
-
-
-
-
Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine
-
-
-
-
-
-
-
Lipocine Announces 2019 Year End Financial and Operational Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 01/17: (LPCN) (TA) (KNX) Higher; (SIG) (FUL) (MS) Lower (more...)
-
-
-
-
-
-
-
Lipocine Announces Financial and Operational Results for the Second Quarter and Six Months Ended June 30, 2017
-
1,198,616 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

